- Generic name
- Rifampicin
- Strength
- 150 mg
- Dosage form
- Capsule
- Manufactured by
- Dolphin Pharmaceuticals Ltd.
D Rifampicin Capsule
About D Rifampicin 150 mg Capsule
Made by Dolphin Pharmaceuticals Ltd., D Rifampicin is a capsule whose active ingredient is Rifampicin. The medicine is not for treating viral infections like colds or flu.
There are 18 brands of Rifampicin listed in Bangladesh. The lowest listed price is Firifam 150 mg Tablet at ৳ 1 per unit.
What is D Rifampicin 150 mg Capsule?
D Rifampicin 150 mg is a capsule product of Dolphin Pharmaceuticals Ltd. that contains Rifampicin. D Rifampicin 150 mg capsule is an anti-tubercular antibiotic. Whether it suits you is a decision for your doctor.
Uses of D Rifampicin
The medicine is not for treating viral infections like colds or flu. It is not used alone for tuberculosis because resistance can develop. It is also used in the meningococcal carrier state. Your doctor will confirm what you need and how long you should take it.
How to use D Rifampicin
Take the capsule by mouth with a full glass of water. D Rifampicin is taken by mouth. Swallow the capsule whole with water. The doctor decides the dose and how long you take it, and any missed dose should be discussed with your doctor or pharmacist. The dose and duration of treatment depend on your individual condition and will be decided by your doctor.
Side effects of D Rifampicin
Stomach upset, including nausea, vomiting, loss of appetite, diarrhoea, and indigestion, is possible. Gastrointestinal effects such as nausea, vomiting, loss of appetite, diarrhoea, and stomach discomfort can occur. Serious effects are possible; tell your doctor about any side effect. Contact your doctor if you notice yellowing of the eyes or skin, dark urine, severe tiredness, or any unusual bleeding or bruising. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
In late pregnancy, it can cause bleeding in mother and infant. Rifampicin can affect the liver, so people with liver disease need caution and medical supervision, and the doctor may arrange liver function monitoring before and during treatment. It may interact with many medicines, including antacids, ketoconazole, phenytoin, and halothane. Keep out of reach of children.
Frequently asked questions
Why is D Rifampicin prescribed?
The medicine is not for treating viral infections like colds or flu. It is not used alone for tuberculosis because resistance can develop.
How should I take D Rifampicin?
Take the capsule by mouth with a full glass of water. D Rifampicin is taken by mouth.
What should I watch for while using D Rifampicin?
Stomach upset, including nausea, vomiting, loss of appetite, diarrhoea, and indigestion, is possible. Gastrointestinal effects such as nausea, vomiting, loss of appetite, diarrhoea, and stomach discomfort can occur.
Who should be careful with D Rifampicin?
In late pregnancy, it can cause bleeding in mother and infant. Rifampicin can affect the liver, so people with liver disease need caution and medical supervision, and the doctor may arrange liver function monitoring before and during treatment.
Indications
Pharmacology
Dosage & Administration
Tuberculosis:
- Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
- Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.
Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.
Interaction
Contraindications
Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.
Side Effects
Pregnancy & Lactation
Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Precautions & Warnings
In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.
Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.
Overdose Effects
Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.
Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.
Storage Conditions
Alternative brands of Rifampicin
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.